Tumour dormancy: Not so sleepy after all

Nature Medicine

Volumn 1, Issue 2, 1995, Pages 117-118

  Murray, Cliff ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; PROTEIN P53; THROMBOSPONDIN; VASCULOTROPIN;

APOPTOSIS; ETIOLOGY; FIBROSARCOMA; GENE EXPRESSION; HUMAN; LEWIS CARCINOMA; MELANOMA; METASTASIS; NONHUMAN; NOTE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

APOPTOSIS; HUMAN; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0028900541     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0295-117     Document Type: Article

References (18)

1. Holmgren, L., O'Reilly, M.S. & Folkman, J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153 (1995)
2. Folkman, J., Merler, E., Abernathy, C. & Williams, G. Isolation of a tumour factor responsible for angiogenesis. J. exp. Med. 133, 275-288 (1971).
3. Folkman, J. Tumor angiogenesis: Therapeutic implications. New. Engl. J. Med. 285, 1182-1186 (1971).
4. Folkman, J. What is the evidence that tumors are angiogenesis dependent. J. natl. Cancer Inst. 82, 4-6 (1990).
5. Kim, KJ. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844 (1993).
6. Hori, A. et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res. 51, 6180-6184 (1991).
7. Rastinejad, F., Polverini, P. & Bouk, N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-355 (1989).
8. Dameron, K.M., Volpert, K.V., Tainsky, M.A. & Bouk, N.P. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584 (1994).
9. Van Meir, E.G. et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet. 8, 171-176 (1994).
10. O'Reilly, M.S., et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
11. Weinstat-Saslow, D.L. et al. Transfection of thombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, mestastatic potential, angiogenesis. Cancer Res. 54, 6504-6511 (1994).
12. Demicheli, R. et al. Local recurrences following mastectomy: Support for the concept of tumor dormancy. J. natl. Cancer Inst. 86, 45-48 (1994).
13. Weidner, N., Semple, J., Welch, W. & Folkman, J. Tumor angiogenesis correlates with metastasis in invasive breast carcinoma. New. Engl. J. Med. 324, 1-8 (1991).
14. Fox, S.B. et al. relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 53, 4161-4163 (1993).
15. Schultz-Hector, S. & Haghayegh, S. β-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 53, 1444-1449 (1993).
16. Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095-1104 (1991).
17. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenessis. Nature 359, 843-845 (1992).
18. Plate, K.H., Breier, G., Weich, H.A. & Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848 (1992).